Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...

Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic. If the settlement is finalized, it will ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

Aims to revolutionize pharmaceutical manufacturing with focus on advanced aseptic processing technology.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

Officials in states and local governments claimed that the opioid crisis was exacerbated by Purdue Pharma’s OxyContin and ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

MISSOULA, Mont. — NBC MT Today: Impact of grant, loan pause; Purdue Pharma settlement; record year at MSO ...